Nymox Pharmaceutical Climbs 6.9% (NYMX)

Shares of Nymox Pharmaceutical Corporation NYMX are trading up 6.9% at $7.12 per share during the Friday afternoon trading session. The day's range for shares of Nymox Pharmaceutical Corporation has been between $6.60 and $7.17 per share. The average price target of analysts who cover Nymox Pharmaceutical Corporation (NYMX) is $14.50 per share. Volume of 113,000 shares is just above the daily average volume of 112,000 shares. Nymox Pharmaceutical Corporation is a biotechnology company engaged in the research and development of therapeutics and diagnostics, with a particular emphasis on products targeted for the unmet needs of the aging population. In addition to NX-1207 for BPH, Nymox Pharmaceutical Corporation has a number of drug development programs for oncology (prostate cancer and hepatocellular carcinoma), Alzheimer's disease, E. coli food contamination, and other indications. Read more from Benzinga's Company news.